The triple-marker test in predicting fetal aneuploidy: A compromise between sensitivity and specificity

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 88, Issue 1, 2000, Pages 49-55

  Huderer Duric, Koraljka ^a   Skrablin, Snjezana ^a   Kuvacic, Ivan ^a   Sonicki, Zdenko ^a   Rubala, Drago ^a   Suchanek, Ernest ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Down's syndrome; Triple marker test; Trisomy 18; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; ESTRIOL; GONADOTROPIN;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS KARYOTYPING; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SCREENING; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 0033988362     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00121-9     Document Type: Article

References (23)

1. Merkatz I.R., Nitowsky H.M., Macri J.N., Johnson W.E. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol. 148:1984;886-894.
2. Bogart M.H., Pandian M.R., Jones O.W. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 7:1987;623-630.
3. Canick J.A., Knight G.J., Palomaki G.E., Haddow J.E., Cuckle H.S., Wald N.J. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol. 95:1988;330-333.
4. Wald N.J., Cuckle H.S. Densem JW. et al. Maternal serum screening for Down′s syndrome in early pregnancy. Br Med J. 297:1988;883-887.
5. Cheng E.Y., Luthy D.A., Zebelman A.M., Williams M.A., Lieppman R.E., Hickok D.E. A prospective evaluation of a second trimester screening test for fetal Down′s syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol. 81:1993;72-77.
6. Wenstrom K.D., Desai R., Owen J., DuBard M.B., Boots L. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥35 years old. Am J Obstet Gynecol. 173:1995;1287-1291.
7. Kellner L.H., Weiss R.R., Weiner Z. et al. The advantages of using triple-marker screening for chromosomal abnormalities. Am J Obstet Gynecol. 172:1995;831-836.
8. Heyl P.S., Miller W., Canick J.A. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol. 76:1990;1025-1031.
9. Hook E.B. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 58:1981;282-285.
10. Skrablin S., Kuvacic I., Fuduric I., Lesin J., Huderer-Duric K., Suchanek E. The consequences of early amniocentesis. Gynaecol Perinatol. 5:1996;129-132.
11. Sas Institute INC., Sas/STAT Software: Changes and enhacement through release 6.12, Cary, NC: Sas Institute INC., 1997;1167:423-530.
12. Suzumori K., Tanemura M., Murakami I. et al. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Prenat Diagn. 17:1997;861-866.
13. Watt H.C., Wald N.J., Smith D., Kennard A., Dansem J. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn. 16:1996;691-698.
14. Barkai G., Goldman B., Ries L., Chaki R., Cuckle H.S. Ethnic origin and maternal serum markers of Down's syndrome in Israel. Prenat Diagn. 16:1996;870-872.
15. Benn P.A., Jonathan M.C., Collins R. Medians for second-trimester maternal serum α-fetoprotein, human chorionic gonadotrophin, and unconjugated estriol: differences between races or ethnic groups. Clin Chem. 43:1997;333-337.
16. Macri J.N., Kasturi R.V., Krantz D.A., Cook E.J., Sunderji S.G., Larsen J.W. Maternal serum Down's syndrome screening: unconjugated estriol is not useful. Am J Obstet Gynecol. 162:1990;672-673.
17. MacDonald M.L., Wagner R.M., Slotnick R.N. Sensitivity and specificity of screening for Down's syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. Obstet Gynecol. 77:1991;63-68.
18. Reynolds T.M., Nix A.B., Dunstan F.D., Dawson A.J. Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening. Obstet Gynecol. 81:1993;447-450.
19. Haddow J.E., Palomaki G.E., Knight G.J. et al. Prenatal screening with Down′s syndrome with use of maternal serum markers. N Engl J Med. 327:1992;588-593.
20. Phillips O.P., Elias S., Shulman L.P., Andersen R.N., Morgan C.D., Simpson J.L. Maternal serum screening for fetal Down's syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol. 80:1992;353-358.
21. Philip J., Bang J. Outcome of pregnancy after amniocentesis for chromosomal analysis. Br Med J. 2:1978;1183-1184.
22. Hanson F.W., Tennant F.R., Zorn E.M., Samuels S. Analysis of 2136 genetic amniocenteses: experience of a single physician. Am J Obstet Gynecol. 152:1985;436-443.
23. Pauker S.P., Pauker S.G. Prenatal diagnosis - why is 35 a magic number? N Engl J Med. 330:1994;1151-1152.